- Sadeghzadeh-Bazargan A, Ghassemi M, Goodarzi A, Roohaninasab M, Najar Nobari N, Behrangi E. Systematic review of low-dose isotretinoin for treatment of acne vulgaris: focus on indication, dosage, regimen, efficacy, safety, satisfaction, and follow up, based on clinical studies. Dermatol Ther. 2021;34(1):e14438. doi:10.1111/dth.14438.
- The iPledge REMS Perscriber Guide. Published online October 2021. https://ipledgeprogram.com/#Main/Resources.
- Kerr KW, Wosinska ME. Patient access in restrictive risk management programs: the case of iPLEDGE. Ther Innov Regul Sci. 2017;51(1):16–23. doi:10.1177/2168479016663266.
- Shah N, Smith E, Kirkorian AY. Evaluating the barriers to isotretinoin treatment for acne vulgaris in pediatric patients. J Am Acad Dermatol. 2021;85(6):1597–1599. doi:10.1016/j.jaad.2020.11.055.
- Shah N, Kirkorian AY. The future of iPLEDGE: We pledge for more inclusive access to isotretinoin. Pediatr Dermatol. 2021;38(S2):183–184. doi:10.1111/pde.14673.
- Cook M, Perche P, Feldman S. Oral vitamin A for acne management: a possible substitute for isotretinoin. J Drugs Dermatol. 2022;21(6):683–686. doi:10.36849/JDD.6781.
- American Academy of Dermatology Association disappointed by iPLEDGE REMS Program transition. https://www.aad.org/news/aada-disappointed-ipledge-transition. Accessed June 28, 2022.
- Zamil DH, Burns EK, Perez-Sanchez A, Katta R. Do you know how to assess risks posed by over-the-counter vitamin A supplements? AMA J Ethics. 2022;24(5):E376–381. doi:10.1001/amajethics.2022.376.
- Accutane Medication Guide. Published online 2008. https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/018662s059lbl.pdf.
- Zamil DH, Burns EK, Perez-Sanchez A, Parke MA, Katta R. Risk of birth defects from vitamin A “acne supplements” sold online. Dermatol Pract Concept. 2021;11(3):e2021075. doi:10.5826/dpc.1103a75.
- iPLEDGE REMS. https://ipledgeprogram.com/#Main/PublicHome. Accessed June 28, 2022.
Ignoring the elephant in the room—overregulated isotretinoin and unregulated dietary supplements in the United States
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.